Clin2
NCT05794087Worth exploringRecruiting

Study of lung inflammation after ozone exposure

Air Pollution

Treatments studied

Part of Lungs & breathing clinical trials.

This trial studies how immune cells in the lungs respond after ozone exposure, to better understand lung injury. It may help researchers learn what drives inflammation and what could protect the lungs in the future.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
120 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You do not have cardiovascular disease.
  • You do not have a current or ongoing respiratory disease.
  • You have not had recent (within 4 weeks) respiratory or COVID-19 symptoms.
  • You do not have diabetes.
  • You are not pregnant.
  • You are able to produce a sputum plug during screening.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05773001Recruiting· Phase 1
Study of an immune treatment for ozone-related lung inflammation

This early-phase study tests how an immune-targeting treatment affects inflammation in the lungs after ozone exposure. It may help researchers understand—and eventually reduce—lung inflammation triggered by air pollution.

Durham, North Carolina
NCT06943989Enrolling by invitation
Breathing ozone vs. clean air at rest

This study tests how resting healthy adults respond to breathing low levels of ozone (a common air pollutant) compared to clean air. Researchers will measure lung function and signs of inflammation in your blood or breath.

Chapel Hill, North Carolina
NCT07493629Recruiting
Study on immune status and disease control in inflammatory airway diseases

This study looks at how the immune system works and how well diseases like asthma, COPD, and others are controlled. You may join if you have one of these conditions or if you are a healthy volunteer or smoker without lung disease.

Ningbo, Zhejiang
NCT06552364Not yet recruiting· Phase 4
Testing inhaled steroids for COPD and air pollution

This trial tests whether inhaled corticosteroids (steroid inhalers) help people with mild-to-moderate COPD breathe better in areas with higher air pollution. You may join if you have mild-to-moderate COPD, are between 40 and 80, and haven't smoked for at least six months.

NCT07376161Enrolling by invitation
Inflammation and oxidative stress study in stable COPD

This study looks at how inflammation and oxidative stress affect COPD. It tests whether a pulmonary rehabilitation program helps reduce these factors in people with stable COPD who are former smokers.

Istanbul, Kadikoy
NCT06144476Recruiting
Lung inflammation study in healthy and diseased lungs

This study compares the lungs of people with airway disease to healthy volunteers to understand inflammation and lung function. You may be eligible if you have airway disease or are a healthy adult.

London, London

Hear when a new Air Pollution trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.